Acute Urinary Retention
Sudden inability to void with painful bladder distension
All Pathways
UrologyEmergency
Acute Urinary Retention Management (EAU 2024)
Acute Urinary Retention Management (EAU 2024): Acute Urinary Retention → Initial Assessment → Signs of UTI/Urosepsis? → ⚠️ Emergent Decompression → Uret...
Pathway Overview
14 steps
Algorithm Steps
14 total
01Start 02Action Initial Assessment
Confirm diagnosis and identify cause
- Confirm distended, palpable bladder
- Time since last void
- Pain level assessment
- History: BPH, stricture, prior retention
- Medications: anticholinergics, opioids, antihistamines
- Recent surgery/anesthesia
03Decision Signs of UTI/Urosepsis?
Fever, dysuria, bacteriuria
04Warning ⚠️ Emergent Decompression
UTI + obstruction = urosepsis risk
- Immediate catheterization
- Blood/urine cultures
- IV antibiotics
- Monitor for sepsis
05Action Urethral Catheterization
16 Fr Foley catheter with 5-10mL balloon
- Standard 16 Fr Foley first attempt
- Generous lubrication (lidocaine gel)
- Inflate 5-10mL balloon once urine flows
- Document volume drained
- Rapid complete drainage is safe
06Decision Catheter Passes Easily?
Any resistance or difficulty?
07Action Post-Drainage Management
Address underlying cause
- Document volume drained
- UA + culture
- BMP (check creatinine)
- Start alpha-blocker (tamsulosin 0.4mg daily)
- 5-alpha reductase inhibitor if prostate enlarged
08Action Evaluate Underlying Cause
Determine etiology of retention
- BPH (most common in older men)
- Urethral stricture
- Medication-induced
- Constipation/fecal impaction
- Neurogenic (diabetes, spinal cord)
- Post-operative (anesthesia, pain meds)
09Action Plan Voiding Trial
After 72h alpha-blocker therapy
- Remove catheter in AM
- Fill bladder to 300mL or as tolerated
- Check post-void residual
- Success: PVR <200mL
- Failure: PVR >400mL or unable to void
- 23-40% void spontaneously within 72h
10Decision Voiding Trial Successful?
Able to void with low PVR
11Outcome Successful Voiding
Continue alpha-blocker, urology follow-up
- Continue tamsulosin
- Urology follow-up in 2-4 weeks
- Monitor for recurrence
- Consider TURP if recurrent
12Outcome Failed Voiding Trial
Recatheterize, plan intervention
- Recatheterize
- AUA: Require 2 failed voiding trials before surgery
- Consider clean intermittent catheterization
- Urology referral for TURP or other intervention
- Long-term catheter if not surgical candidate
13Action Difficult Catheterization
Stepwise approach for difficult cases
- Try coude tip catheter (for BPH)
- Urology consult
- Flexible cystoscopy + guidewire
- Council catheter over wire
- Suprapubic catheter if urethra impassable
14Action Suprapubic Catheterization
If urethral access impossible
- Ultrasound guidance preferred
- Confirm distended bladder on imaging
- Contraindicated if bladder not distended
- Caution if prior lower abdominal surgery
- Use SPC kit or needle aspiration
- Path rejoins step 07Shared downstream outcome
- Path rejoins step 07Shared downstream outcome
- Path rejoins step 05Shared downstream outcome
Guideline Source
EAU Guidelines on Non-Neurogenic Male LUTS 2024
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Does not address pediatric urinary retention
- Neurogenic bladder requires specialized management
- Does not fully address female-specific causes
- Chronic retention may require different approach
- Does not address post-operative retention in detail
Contraindicated Populations
pediatricneurogenic_bladder_complex
Applicable Regions
USEUAU
AU: Follow local protocols for catheter management
EU: EAU LUTS guidelines provide similar recommendations
US: AUA guidelines recommend alpha-blocker + voiding trial approach
Version 1Next review: 2028-01-11
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the Acute Urinary Retention Management (EAU 2024)?
The Acute Urinary Retention Management (EAU 2024) is a emergency clinical algorithm for Urology. It provides a structured decision tree to guide clinical decision-making, based on EAU Guidelines on Non-Neurogenic Male LUTS 2024.
What guideline is the Acute Urinary Retention Management (EAU 2024) based on?
This algorithm is based on EAU Guidelines on Non-Neurogenic Male LUTS 2024 (DOI: 10.1016/j.eururo.2013.03.004).
What are the limitations of the Acute Urinary Retention Management (EAU 2024)?
Known limitations include: Does not address pediatric urinary retention; Neurogenic bladder requires specialized management; Does not fully address female-specific causes; Chronic retention may require different approach; Does not address post-operative retention in detail. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Acute Urinary Retention Management (EAU 2024) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free